Johnson & Johnson Sold Hip Implants Abroad After FDA Rejected Sale In The U.S. For Safety Concerns
The health care products giant Johnson & Johnson continued to market an artificial hip in Europe and elsewhere overseas after
johnson johnson sell hip implants abroad fda reject sale  USA  safety concerns health care product giant johnson johnson continue market artificial hip europe overseas